acc01801 |
E3 ubiquitin-protein ligase RBBP6 |
phosphorylation |
Thr984 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01802 |
Lipolysis-stimulated lipoprotein receptor |
phosphorylation |
Thr501 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01803 |
Protein FAM219A |
phosphorylation |
Thr113 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01804 |
NF-kappa-B-activating protein |
phosphorylation |
Thr161 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01805 |
Reticulophagy regulator 2 |
phosphorylation |
Thr279 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01806 |
Putative RNA-binding protein 15B |
phosphorylation |
Thr532 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01807 |
Polyhomeotic-like protein 3 |
phosphorylation |
Thr609 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01808 |
ATP-binding cassette sub-family F member 1 |
phosphorylation |
Thr108 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01809 |
RNA polymerase-associated protein LEO1 |
phosphorylation |
Thr629 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01810 |
Transcriptional repressor p66-beta |
phosphorylation |
Thr120 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01811 |
SEC14-like protein 1 |
phosphorylation |
Thr234 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01812 |
Symplekin |
phosphorylation |
Thr1257 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01813 |
Lethal(3)malignant brain tumor-like protein 2 |
phosphorylation |
Thr76 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01814 |
Myocardin-related transcription factor A |
phosphorylation |
Thr450 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01815 |
Mitochondrial outer membrane protein SLC25A46 |
phosphorylation |
Thr45 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01816 |
60S ribosomal export protein NMD3 |
phosphorylation |
Thr470 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01817 |
BUD13 homolog |
phosphorylation |
Thr159 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01818 |
Echinoderm microtubule-associated protein-like 4 |
phosphorylation |
Thr897 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01819 |
Echinoderm microtubule-associated protein-like 4 |
phosphorylation |
Thr899 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01820 |
Inner centromere protein |
phosphorylation |
Thr213 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01821 |
Tight junction protein ZO-2 |
phosphorylation |
Thr933 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01822 |
LIM and calponin homology domains-containing protein 1 |
phosphorylation |
Thr215 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01823 |
Protein PRRC2C |
phosphorylation |
Thr1267 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01824 |
Glyceraldehyde-3-phosphate dehydrogenase |
oxidation |
Met175 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01825 |
"Actin, cytoplasmic 1" |
oxidation |
Met44 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01826 |
"Actin, cytoplasmic 1, N-terminally processed" |
oxidation |
Met44 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01827 |
"Actin, cytoplasmic 2" |
oxidation |
Met46 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01828 |
"Actin, cytoplasmic 2, N-terminally processed" |
oxidation |
Met46 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01829 |
"Actin, alpha skeletal muscle" |
oxidation |
Met45 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01830 |
"Actin, alpha skeletal muscle, intermediate form" |
oxidation |
Met46 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01831 |
"Actin, cytoplasmic 1" |
oxidation |
Met47 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01832 |
"Actin, cytoplasmic 1, N-terminally processed" |
oxidation |
Met47 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01833 |
"Actin, cytoplasmic 2" |
oxidation |
Met49 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01834 |
"Actin, cytoplasmic 2, N-terminally processed" |
oxidation |
Met49 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01835 |
"Actin, alpha skeletal muscle" |
oxidation |
Met48 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01836 |
"Actin, alpha skeletal muscle, intermediate form" |
oxidation |
Met49 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01837 |
Peptidyl-prolyl cis-trans isomerase A |
oxidation |
Met100 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01838 |
Cyclin-dependent kinase 2 |
phosphorylation |
Tyr15 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01839 |
Cyclin-dependent kinase 3 |
phosphorylation |
Tyr15 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01840 |
Paxillin |
phosphorylation |
Tyr118 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Negative |
4.0 (Moderate) |
PXD001812
|
acc01841 |
Shootin-1 |
oxidation |
Met507 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Positive |
4.0 (Moderate) |
PXD005514
|
acc01842 |
AT-rich interactive domain-containing protein 1A |
oxidation |
Met384 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Positive |
4.0 (Moderate) |
PXD005514
|
acc01843 |
AT-rich interactive domain-containing protein 1A |
oxidation |
Met387 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Positive |
4.0 (Moderate) |
PXD005514
|
acc01844 |
AT-rich interactive domain-containing protein 1A |
oxidation |
Met1759 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Positive |
4.0 (Moderate) |
PXD005514
|
acc01845 |
Histone-lysine N-methyltransferase 2D |
oxidation |
Met1605 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Positive |
4.0 (Moderate) |
PXD005514
|
acc01846 |
Protein phosphatase 1 regulatory subunit 12A |
oxidation |
Met308 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Positive |
4.0 (Moderate) |
PXD005514
|
acc01847 |
Protein transport protein Sec16A |
oxidation |
Met1432 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Positive |
4.0 (Moderate) |
PXD005514
|
acc01848 |
Syntaxin-6 |
oxidation |
Met3 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Negative |
4.0 (Moderate) |
PXD005514
|
acc01849 |
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 |
oxidation |
Met441 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Negative |
4.0 (Moderate) |
PXD005514
|
acc01850 |
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 |
oxidation |
Met444 |
human |
Breast Cancer |
MCF7-LTED |
palbociclib |
Negative |
4.0 (Moderate) |
PXD005514
|